Gray Zone - Diverging Roads in the Management of Metastatic EGFR Mutated NSCLC: Ablate All, None, or Some?
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Lung Cancer
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
Gray Zone - Neoadjuvant Chemoimmunotherapy for Initially Resectable NSCLC: Queen's Gambit or CheckMate?
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Lung Cancer
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
ASTRO/ESTRO Joint Session – Overview of ASTRO/ESTRO Oligometastatic NSCLC Clinical Practice Guidelines: Case-Based Interactive Discussion
One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.
Category
  • Other
  • Lung Cancer
Format
  • CME only
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance